Wockhardt will sell its animal healthcare business for an amount not less than Rs 150 crore. The company on Wednesday proposed the divestment of this asset through a postal ballot that will close on June 1, 2009. While...
Pfizer may buy RFCL’s veterinary co for Rs 250 cr
GlobaL pharma giant Pfizer has emerged as the frontrunner to acquire RFCL’s animal health unit, Vetnex, in a deal estimated around Rs 250 crore, people familiar with the situation said. This follows the ICICI...
GlaxoSmithKline buys US skincare firm Stiefel for $3.6 bn
British drugs firm GlaxoSmithKline (GSK) said Monday it will buy Stiefel Laboratories, US maker of anti-itching creams, acne treatments and other skincare products, for as much as $3.6 billion. The deal for Stiefel...
FIs object to Pfizer’s open offer for arm
Financial Institutions led by the Life Insurance Corporation (LIC) are objecting to US pharma major Pfizer Inc’s open offer to increase stake in its Indian arm from 41% to 75% on the ground that the offer price of...
Adcock’s plan to buy Medpro hits Cipla hurdle
South African company Adcock Ingram’s plans to buy Cipla Medpro, with whom Indian pharma major Cipla has a 20-year drug-supply agreement, has run into trouble with the Mumbai-based company opposing the $228...
Sun Pharma buys Novartis brands for Rs 1,900 cr
Sun Pharmaceuticals, India’s largest drug maker by sales, has acquired Novartis’ branded drug portfolio in Japan for $293 million (Rs 1,900 crore). With this, Sun will gain a strong foothold in Japan, the...
Sun Pharma to sell AstraZeneca’s diabetes drug in India
Homegrown drug major Sun Pharma on Wednesday entered into a partnership with AstraZeneca for distribution of the latter’s diabetes medicine dapagliflozin in India. As part of the pact, Sun Pharma will sell...
Flipkart arm Ekart ties up with Apollo Pharmacy for delivery and pickup services.
Ekart, the logistics unit of Flipkart, is rolling out two new initiatives aimed at improving efficiency and capacity utilisation. It has tied up with Apollo Pharmacy for delivery and pickup of products like smartphones...
Taro Pharma to buy back shares worth $250 mn
Taro Pharma, the Israeli subsidiary of Sun pharmaceutical, has decided to buy back its shares worth $250 million. The repurchase authorisation enables the company to purchase its ordinary shares from time to time...
South Africa’s Adcock in talks to sell part of its India business.
South Africa’s second largest drug maker Adcock Ingram is in advanced talks to sell part of its India business to Oaknet Lifesciences, an entrepreneurial venture set up last year by RS Raghav, a former Lupin...
Cipla seals Invagen and Exelan deals in US.
India’s third largest drug maker CiplaBSE 0.54 % has closed the acquisitions of InvaGen and Exelan, the two drug companies it purchased last September in an all cash transaction worth $550 million. The development...
U.S. drugmaker Pernix Therapeutics explores sale
Pernix Therapeutics Holdings Inc (PTX.O), a U.S. specialty pharmaceutical company, is exploring strategic alternatives, including a potential sale, people familiar with the matter said on Monday. The Morristown, New...
